Orthogen Corp.

Other News To Note.
BIOWORLD Today; 11/3/2009; 1294 words; ...prospective, randomized, blinded and controlled study. CytRx Corp., of Los Angeles, said the FDA has cited two actions needed...NITR) under the Korean Food and Drug Administration (KFDA). Orthogen AG, of Dusseldorf, Germany, said results of a 400-patient...

Research results from H. Alexander and co-authors update knowledge of bone research.(Report)
Blood Weekly; 3/26/2009; 639 words; ...2009;88B(2 Sp. Iss.):306-311). Additional information can be obtained by contacting H. Alexander, Orthogen Corp., 505 Morris Avenue, Suite 104, Springfield, NJ 07081, USA. The publisher of the Journal of Biomedical Materials...

Clinic Roundup.
BIOWORLD Today; 8/5/2008; 973 words; ...added to statin. The compound was safe and well tolerated. Orthogen AG, of Dusseldorf, Germany, published a two-year study...bioequivalence study previously conducted for PA32540. Schering-Plough Corp., of Kenilworth, N.J., said top-line results from a...

OTHER NEWS TO NOTE.(Agenix Ltd. and Diosynth Biotechnology)(Biotech Holdings Ltd. to issue shares)(Genoptix Inc. completed its financing)
BIOWORLD Today; 8/11/2005; 1907 words; ...prospective, randomized, blinded and controlled study. CytRx Corp., of Los Angeles, said the FDA has cited two actions needed...NITR) under the Korean Food and Drug Administration (KFDA). Orthogen AG, of Dusseldorf, Germany, said results of a 400-patient...

FDA approval granted for Silhouette Laser-Lok dental implants.
Medical Devices & Surgical Technology Week; 11/28/2004; 674 words; ...said. Silhouette Laser-Lok Implant will be available for sale on December 1, 2004. Hollander said, "BioLok and Orthogen Corp., its wholly owned R&D division headed up by Harold Alexander, PhD, have been developing this surface for...